
    
      The investigators will compare adenosine interstitial levels using a parallel design study
      with three groups of subjects. Forearm interstitial adenosine levels will be measured at
      baseline and after intrabrachial infusion of adenosine at two doses. Subjects will then
      randomly receive Ticagrelor 180 mg, Dipyridamole 200 mg, or placebo. Two hours later the
      investigators will repeat the dialysate collections at baseline and after adenosine
      infusions.
    
  